ERIN KRAMER: Open Payments
NPI 1740872514 · BALLWIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 15 payments from 9 companies in 2025. Trend: 2023 $15 · 2024 $431 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $74 |
| ABBVIE INC. | 2 | $43 |
| Novo Nordisk Inc | 2 | $41 |
| Amgen Inc. | 2 | $34 |
| Lilly USA, LLC | 2 | $33 |
| Exact Sciences Corporation | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: PAXLOVID, UBRELVY, OTEZLA, MOUNJARO, Ozempic, ELIQUIS, Cologuard Collection Kit, CONTRAVE.
Industry payments across MO — which companies pay providers there.
